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Abstract
Background Patients with type 2 diabetes have an increased risk of developing microvas-
cular and macrovascular complications. In routine diabetes care an adequate reduction of
risk factors for these complications is often not achieved.
Objective The aim of the study was to evaluate the effects of structured diabetes care on
clinical outcomes of patients with type 2 diabetes in primary care.
Methods We performed a quasi-experimental study on the effects of structured care
consisting of organizational and educational components (n = 581) compared with care-
as-usual (n = 152). We assessed clinical outcomes of HbA1c, blood pressure, cholesterol,
creatinine and body mass index, at baseline and after 1 year. The long-term effects in the
structured care group were determined after another 2 years.
Results Structured care led to improvement in HbA1c and long-term improvements in
blood pressure and cholesterol compared with care-as-usual. After 1 year, the percentage of
patients who did not deteriorate was higher in the structured care group, again for HbA1c,
diastolic blood pressure, low-density lipoprotein cholesterol and body mass index.
Conclusions Structured diabetes care consisting of multiple components has a positive
effect on clinical outcomes compared with care-as-usual. Our findings support its further
implementation in order to reduce complications in type 2 diabetes patients.
Introduction
Patients with type 2 diabetes have an increased risk of developing
microvascular and macrovascular complications. Several studies
conclude that intensive glycaemic control and blood pressure
control in type 2 diabetes reduces the risk of complications [1,2].
Hence, care should be aimed at reducing total cardiovascular risk
by strict glycaemic, blood pressure and lipid control, and further-
more by encouraging lifestyle changes especially where weight
control is concerned.
Although the evidence for the effects of reducing complication
risk is convincing, this reduction is often not reached in routine
diabetic care. Studies show that patients not only have poor meta-
bolic control, but that laboratory measurements, patient education
and behavioural activities are also not performed frequently
enough [3,4]. Attempts have been made to organize care in such a
way that it can achieve the high demands of diabetes care, using
various care models and interventions. Many of these care models
have focused on one or two main aspects, such as patient educa-
tion, changes in cooperation or training of health care professional
[5–7]. Effective approaches for chronic diseases have often been
multifaceted, involving different combinations of various types of
education for the health care professionals, registration systems,
organizational changes, doctor feedback and patient education and
support [3,8,9]. A multifaceted approach may also be effective in
diabetes care.
It is still unclear from research whether multifaceted care can be
effective in everyday practice. Studies have only targeted a select
group of patients, such as poorly controlled diabetes patients [10]
or they have not been conducted in an everyday primary care
setting. If multifaceted structured care (SC) is to be implemented
more widely, then clearly more evidence is needed to establish its
efficacy. Moreover, such evidence should be provided from studies
that include the effects of a number of clinical outcomes, such as
blood pressure, cholesterol and body mass index (BMI). To date,
most studies have only used glycaemic control (measured by
HbA1c) as the main outcome measure, even though this measure
only accounts for part of the added cardiovascular risk [11,12].
In this study, we therefore assessed the effects of multifaceted
diabetes care, consisting of a number of organizational and
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educational components, on several clinical outcomes in a routine
primary care setting. The aim of the study was to evaluate the
effects of this structured diabetes care.
Methods
Design
This study involved a quasi-experimental study on the effects of
SC compared with care-as-usual (CAU) on clinical outcomes. We
collected clinical outcomes at baseline and after 1 year. The long-
term effects in the SC group were subsequently determined for a
further 2 years.
Study population, practices and patients
General practices in the north of the Netherlands voluntarily par-
ticipated in the SC intervention study from the beginning of 2003.
At the time of data collection in 2006 the SC group consisted of 24
general practices, from which a total of 795 patients were sampled.
Of these practices, 11 participated since 2003 or 2004. The length of
follow-up differed as a consequence of the different enrolment time
of the practices. For the CAU control group, practices were eligible
if they did not participate in a diabetes-specific care improvement
programme and were located in a region comparable to that of the
SC group. This CAU group consisted of 14 general practices that
took part in another effect study. The intervention in that study could
not affect our findings because it started after the completion of our
data collection. In each practice, 15 patients diagnosed with type 2
diabetes were randomly sampled. These patients were subsequently
informed; if they objected against anonymous data retrieval, a next
patient was selected. The design of the study was agreed upon by he
local Medical Ethics Committee.
Intervention
The care was organized in accordance with the national clinical
guidelines of the Dutch College of General Practitioners (Box 1)
[13] in combination with a number of organizational and educa-
tional components. Organizational aspects consisted of multidis-
ciplinary cooperation, a clear task division and cooperation
between the general practitioner, diabetes specialized nurse, prac-
tice nurse and dietician (Box 2). Also, all relevant clinical param-
eters were registered in a structured registration programme called
Diabcare, and used for comparisons within and between practices.
The diabetes nurse discussed these parameters and process indi-
cators with the general practitioner on an annual basis.
The educational component targeted both patients and health
care professionals. The patients received individual education from
a diabetes specialized nurse and a dietician. In addition, they
received a ‘diabetes passport’ to record medication, laboratory
results, treatment targets and personal information. The health care
professionals took part in an education programme consisting of
lectures on a number of relevant topics, such as neuropathy and diet.
Care-as-usual
The practices included in the control group for the study provided
diabetes CAU. CAU was based on the national guidelines of the
Dutch College of General Practitioners, and consisted of four
checks per year, involving three general and one more extensive
checks a year (Box 1) [13].
Measures
The following clinical outcomes were collected: glycosylated hae-
moglobin (HbA1c), total cholesterol, high-density lipoprotein
Box 1 Guidelines of the Dutch College of General Practioners.
• 3-monthly checks
Inquire after: well-being; possible hypo- or hyperglycaemia; diet,
exercise or medication difficulties
Determine: weight, fasting glucose
Patients on insulin (2–4 days): determine HbA1c and 4-point day
curve.
Patients on hypertensive: determine blood pressure
High ulcus risk: feet examination
• Yearly check
Inquire after: vision difficulties, cardiovascular complaints, neur-
opathy and sexual problems
Determine: weight, blood pressure, fasting glucose, HbA1c, crea-
tinine, lipids
Patients on insulin: inspection of injection places
Patients on diuretic or Renin-Angiotensin inhibitors: kalium
Patients with life expectancy >10 years: albumin/creatinine
Perform fundus photography
Box 2 Structured care components.
• Organizational
Multidisciplinary cooperation: Clear task division and cooperation between general practitioner (GP),
diabetes specialized nurse (DSN), practice nurse, dietician.
Standardized reporting between care givers.
Diabetes registration system: Yearly structured entering of all diabetes relevant parameter.
Comparisons possible within and between practices.
Outcome and process indicators discussed by DSN with GP.
• Educational
Patient: According to protocol patient received education from DSN and dietician.
Patient participation and knowledge was stimulated with use of the diabetes passport.
Health care professional: All professionals could participate in the education programme.
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cholesterol, creatinine, blood pressure and BMI. Low-density lipo-
protein (LDL) cholesterol was estimated with the Friedewald
formula [14]. LDL cholesterol was not estimated for patients with
a triglyceride value above the 4.52 mmol L-1 because the Friede-
wald formula then becomes less accurate.
In the SC group, clinical outcomes were collected from all
patients registered in the registration programme, beginning from
the time the practice participated the SC and annually for 3 years
thereafter.
In each practice of the CAU group the clinical outcomes at
baseline (2003) and after 1 year were manually extracted from the
electronic medical records of 15 randomly selected type 2 diabetes
patients using a structured electronic data entry form. A separate
validation study showed good agreement for laboratory parameters
between the two data sources and acceptable agreement for non-
laboratory parameters [15].
Statistical methods
First, response rates and characteristics of practices and patients
were determined. Subsequently, using a two-sample t-test, com-
parisons were made between SC and CAU group for the changes
between baseline and 1-year follow-up. Multiple regression analy-
ses were used, with the change of the clinical outcomes being used
as the outcome variables. The independent variables of baseline
value, duration of diabetes, age, gender, insulin use and start year
of the SC were added to the models. Linear mixed models were
used for the repeated measurements. The sample was divided into
two groups consisting of patients with deteriorated clinical out-
comes and those with equal or improved clinical outcomes. Logis-
tic regression was used to compare the SC and CAU group.
Statistical analyses were performed with SPSS 14.0 and Mlwin
2.02. P-values <0.05 were considered significant.
Results
In the SC group, data were collected from 581 patients (73%) with
data both at baseline (T0) and after 1 year (T1). Data were collected
from 330 patients after 2 years (T2) from 143 patients after 3 years
(T3). The main reason for the low number of patients at T3 was that
only four practices started the SC 3 years before the data collection
(see Fig. 1). In the CAU group T0 and T1 data were available for
152 patients (74%).
The patients for whom there was no baseline and T1 measure-
ment were slightly older (67.9 vs. 65.5 years, P = 0.004), had a
longer history of diabetes (6.9 vs. 5.0 years, P = 0.000), lower
diastolic blood pressure (80.4 vs. 82.5 mmHg, P = 0.006), higher
HbA1c (6.8 vs. 6.6, P = 0.04) and were more often female (60.5%
vs. 49.9%, P = 0.005). They did not differ in mean BMI, systolic
blood pressure, cholesterol, creatinine or insulin use.
Practice and patient characteristics
The characteristics of the SC and CAU group practices and their
patients were very similar, with only diabetes history showing a
longer duration in the SC group (Table 1).
Clinical outcomes
The adjusted change of HbA1c was significantly more favourable
in the SC group than in the CAU group (Table 2). The adjusted
LDL cholesterol was lower in the SC group by 0.2 mmol L-1 after
1 year than in the CAU group, but this difference was not signifi-
cant (P = 0.059) (Table 2). The adjusted changes of systolic and
diastolic blood pressure were also more favourable in the SC group
but did not reach significance (P = 0.073).
No differences between the SC and usual care group were found
in the percentage of patients on insulin after 1 year. Both groups
showed a patient increase of 5%.
Patients in the SC group had significantly higher adjusted odds
for having an equal or improved outcome after 1 year on HbA1c,
diastolic blood pressure, LDL cholesterol and BMI than patients in
the usual care group (Table 3).
Assessment of the long-term effects of the SC showed a signifi-
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Figure 1 Data collection. DM, diabetes mel-
litus; GP, general practitioner.
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HbA1c remained stable after 3 years compared with baseline. A
minor increase was found for creatinine after 1 and 2 years. BMI
remained stable for the first 2 years, but a significant improvement
was found after 3 years.
Discussion
We found that SC leads to improvement in HbA1c and long-term
improvements in blood pressure and cholesterol when compared
Table 1 Baseline characteristics of practices and patients
SC CAU
Practices, n 24 14
Solo, n (%) 13 (54.2) 7 (50.0)
Duo, n (%) 6 (25.0) 5 (35.7)
Group, n (%) 5 (20.8) 2 (14.3)
Patients per practitioner 2234 (646) 1872 (603)
Diabetes patients 76.2 (32.1) 53.9 (30.3)
Patients under treatment internist, % 9.8 (7.4) 11.2 (4.9)
Practice nurse employed, % 68.4 63.6
Patients with 1-year follow-up (n) 581 152
Age (years) 65.8 (11.9) 64.2 (11.5)
Male (%) 49.9 50.7
Insulin use (%) 14.6 15.1
Duration of diabetes (years) 5.2 (5.1)* 3.8 (4.0)*
Patients with also 2-year follow-up (n) 330 –
Age (years) 64.7 (11.5) –
Male (%) 48.5 –
Insulin use (%) 15.5 –
Duration of diabetes (years) 5.0 (4.9) –
Patients with also 3-year follow-up 143 –
Age (years) 64.0 (11.7) –
Male (%) 43.3 –
Insulin use (%) 17.5 –
Duration of diabetes (years) 4.2 (3.7) –
*P < 0.05.
Data are means  SD unless indicated otherwise.
CAU, care-as-usual; SC, structured care.
Table 3 Comparison between structured care and care-as-usual group
in having an equal or improved outcome after 1 year (adjusted odds
ratio)
n OR† 95% CI
HbA1c (%) 474 1.80*a,c 1.03–3.14
Systolic BP (mmHg) 571 1.54a,c 0.99–2.38
Diastolic BP (mmHg) 570 2.13*a 1.37–3.32
Total cholesterol (mmol L-1) 430 1.85b,c 0.91–3.76
HDL cholesterol (mmol L-1) 432 1.22a,e 0.65–2.29
LDL cholesterol (mmol L-1) 386 2.89*a 1.47–5.69
Creatinine (mmol L-1) 462 1.36 0.83–2.22
BMI (kg m-2) 382 2.48*a 1.36–4.46
*P < 0.05.
†Adjusted for: abaseline values, bduration of diabetes, cage, dinsulin use,
egender.
BMI, body mass index; BP, blood pressure; HDL, high-density lipopro-
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with CAU. After 1 year, the percentage of patients who did not
deteriorate was higher in the SC group for HbA1c, diastolic blood
pressure, LDL cholesterol and BMI. This indicated that SC when
compared with usual care had a more positive effect on the clinical
outcomes. As the duration of the disease has an adverse effect on
clinical outcome values, it can be argued that a stable outcome can
be considered to be a positive effect. Therefore, even a small
improvement in clinical outcomes, important for reducing cardio-
vascular risk, may have significant clinical implications for the
diabetes population.
The SC studied here used a comprehensive approach. Multidis-
ciplinary cooperation was supported with a registration pro-
gramme, the health care professionals received besides education
specific benchmark information, the patients received education
and their participation was supported with the use of a diabetes
passport. Other intervention studies that have included multiple
components in primary care have investigated only short-term
effects. The components most often used in these interventions
were multidisciplinary cooperation [16–20], a registration pro-
gramme [16–18], caregiver education [18–20] and patient educa-
tion [17,19]. The effects of these interventions, albeit only
considering the short-term effects, were consistent with our find-
ings, with improvements found in one or more of the clinical
outcomes important for cardiovascular risk. van Bruggen et al.
found improvement in the process in diabetes care, but hardly in
clinical outcomes [21].
There are some diabetes intervention studies that have investi-
gated long-term effects, but these have not included multifaceted
interventions. Ilag et al. and Renders et al. found no effects after 2
and 4 years [22,23]. Peters found an improvement only in HbA1c
that was maintained after 3 years [24]. Olivarius et al. found
improvement in HbA1c, blood pressure and cholesterol after 6
years and Ubink-Veltmaat et al. found improvement in blood pres-
sure and cholesterol after 3 years [7,25]. The elements of these
interventions consisted of patient [25] or caregiver education
[7,22,23], multidisciplinary cooperation [22,24,25], a registration
programme [23,24] or a combination of these, but not with three
components or more. It seems more effects are found in multifac-
eted diabetes interventions.
Strengths and limitations
The strengths of our study were the inclusion of patients involved
in routine primary care, the comparatively long follow-up, the
inclusion of a comparable control group and the use of several
clinical outcomes. The random selection of the sample and the
implementation of the SC in an everyday setting enabled the
results to be generalizable and applicable in a daily practice. A
limitation may have been that the inclusion of practices that vol-
untarily participated in the SC programme may have held an
above-average interest in research to improve quality of care.
However, this is unlikely to have biased our findings because the
control practices also voluntarily participated in a study on effects
of adapted care. Moreover, for some clinical outcomes the SC
group had more favourable baseline values. This suggested that in
the SC group room for improvement was smaller, which may have
led to some underestimation of the effects of SC.
Conclusion
Structured diabetes care that consisted of multiple components
showed a positive effect on clinical outcomes when compared with
usual care. Considering these effects, SC can reduce complications
in type 2 diabetes patients. Further research is needed to determine
the cost-effectiveness of this type of SC and its effects on patient
and health care professional experiences.
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